Загрузка...
Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era
Atrial fibrillation (AF) is a major cause of ischaemic stroke. The majority of these strokes can be prevented by treatment with oral anticoagulation therapy. The advent of non-vitamin K antagonist oral anticoagulants (NOACs) has resulted in a choice of therapeutic agents available to physicians for...
Сохранить в:
| Опубликовано в: : | Ther Adv Chronic Dis |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692140/ https://ncbi.nlm.nih.gov/pubmed/29201334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622317720106 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|